- Open
- 0.43
- High
- 0.45
- Low
- 0.40
- Close
- 0.45
- Change
- -0.03 (-5.88%)
- Volume
- 1,961,590
⌘K
| 4 Jun 2026 | 15:40:11 | Holding(s) in Company |
| 2 Jun 2026 | 12:41:47 | Holding(s) in Company |
| 2 Jun 2026 | 07:00:06 | Study validating economic advantages of PTRA test |
| 2 Jun 2026 | 07:00:06 | AMA grants additional CPT® Code for ProtegaTM |
| 27 May 2026 | 16:04:26 | Holding(s) in Company |
| 7 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 31 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
Verici Dx utilizes advanced sequencing technology to create a customized risk assessment for kidney transplant patients throughout their treatment, while also identifying potential damage earlier than traditional clinical and pathological methods.
| 4 Jun 2026 | 15:40:11 | Holding(s) in Company |
| 2 Jun 2026 | 12:41:47 | Holding(s) in Company |
| 2 Jun 2026 | 07:00:06 | Study validating economic advantages of PTRA test |
| 2 Jun 2026 | 07:00:06 | AMA grants additional CPT® Code for ProtegaTM |
| 27 May 2026 | 16:04:26 | Holding(s) in Company |
| 7 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 31 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
Verici Dx utilizes advanced sequencing technology to create a customized risk assessment for kidney transplant patients throughout their treatment, while also identifying potential damage earlier than traditional clinical and pathological methods.
| 28 Apr 2026 |
| Verici Dx shows stronger signs of commercial adoption |
| 28 Apr 2026 | Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets |
| 22 Apr 2026 | Verici Dx gains commercial momentum as Tutivia adoption builds |
Lord Stevens of Ludgate has interests in this issuer
| 28 Apr 2026 |
| Verici Dx shows stronger signs of commercial adoption |
| 28 Apr 2026 | Verici Dx Shows Strong Momentum with Impressive Q1 Growth, Singer Capital Markets |
| 22 Apr 2026 | Verici Dx gains commercial momentum as Tutivia adoption builds |
Lord Stevens of Ludgate has interests in this issuer